Skip to main content
Maryam Asgari, MD, Dermatology, Boston, MA, Massachusetts General Hospital

MaryamMandanaAsgariMD

Dermatology Boston, MA

Dermatologic Surgery

Physician

Dr. Asgari is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Asgari's full profile

Already have an account?

Education & Training

  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterFellowship, Micrographic Surgery and Dermatologic Oncology, 2004 - 2005
  • University of Washington
    University of WashingtonResidency, Dermatology, 1999 - 2002
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1998 - 1999
  • Yale School of Medicine
    Yale School of MedicineClass of 1997

Certifications & Licensure

  • CO State Medical License
    CO State Medical License 2023 - 2025
  • CA State Medical License
    CA State Medical License 2003 - 2024
  • MA State Medical License
    MA State Medical License 2014 - 2023
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • Fellow (FAAD) American Academy of Dermatology

Publications & Presentations

PubMed

Journal Articles

  • Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults with Atopic Dermatitis  
    Maryam Asgari, MD, JAMA Dermatology
  • Multiple Basal Cell Carcinomas in a Patient with Myotonic Dystrophy Type 1  
    Jessica Feng, Maryam M Asgari, Emergency Medicine Journal

Authored Content

  • Association Between Topical Calcineurin Inhibitor Use and Keratinocyte Carcinoma Risk Among Adults with Atopic DermatitisAugust 2020

Press Mentions

  • USPSTF Issues Updated Recommendations on Skin Cancer Screening
    USPSTF Issues Updated Recommendations on Skin Cancer ScreeningApril 18th, 2023
  • USPSTF: Evidence for Skin Cancer Screening Is Inadequate
    USPSTF: Evidence for Skin Cancer Screening Is InadequateApril 18th, 2023
  • USPSTF Releases Updated Recommendations on Skin Cancer Screening
    USPSTF Releases Updated Recommendations on Skin Cancer ScreeningApril 18th, 2023
  • Join now to see all

Grant Support

  • Nsaid Use In Chemoprevention Of Squamous Cell CarcinomasNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2005–2009
  • The Role Of HPV In Squamous Cell CarcinomaNational Institute Of Arthritis And Musculoskeletal And Skin Diseases2000–2002

Professional Memberships

Hospital Affiliations